Hadean Ventures announces oversubscribed final close of Hadean Capital II
Continue Reading-
Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer
Ribbon Biolabs appoints Jodi Barrientos Chief Executive Officer — Hadean Ventures Home Portfolio Team Impact…
Continue Reading -
Complement Therapeutics Enrols First US Participant
Complement Therapeutics Enrols First US Participant — Hadean Ventures Home Portfolio Team Impact Investors News…
Continue Reading -
Abliva Achieves Important Milestone in the Ongoing FALCON Study
Abliva Achieves Important Milestone in the Ongoing FALCON Study — Hadean Ventures Home Portfolio Team…
Continue Reading -
Abliva’s Lead Candidate KL1333 Receives FDA Fast Track Designation
Abliva’s Lead Candidate KL1333 Receives FDA Fast Track Designation — Hadean Ventures Home Portfolio Team…
Continue Reading -
ARTHEx Biotech Announces Closing of €42 M Series B Financing
ARTHEx Biotech Announces Closing of €42 M Series B Financing — Hadean Ventures Home Portfolio…
Continue Reading -
Complement Therapeutics Secures €72 Million in Series A Financing
Complement Therapeutics Secures €72 Million in Series A Financing...
Continue Reading -
Alex Therapeutics extends financing round to €4.75M with leading life science VC
Alex Therapeutics extends financing round to €4.75M with leading life science VC — Hadean Ventures…
Continue Reading